Experience in patent foramen ovale closure with the CERA Lifetech occluder in patients with cryptogenic stroke

INTRODUCTION: Nowadays, percutaneous closure of patent foramen ovale (PFO) in patients after cryptogenic stroke is becoming a dominating strategy. The most commonly used and investigated device is the Amplatzer occluder. However, several other devices have been designed for transcatheter closure of...

Descripción completa

Detalles Bibliográficos
Autores principales: Węglarz, Przemysław, Węgiel, Michał, Konarska-Kuszewska, Ewa, Kuszewski, Piotr, Staszel, Michał, Dziewierz, Artur, Rakowski, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580839/
https://www.ncbi.nlm.nih.gov/pubmed/37854971
http://dx.doi.org/10.5114/aic.2023.131479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580839/
https://www.ncbi.nlm.nih.gov/pubmed/37854971
http://dx.doi.org/10.5114/aic.2023.131479

Ejemplares similares